Laserfiche WebLink
INTERMEDIX HOLDINGS INC. AND SUBSIDIARIES <br />Notes to Consolidated Financial Statements <br />December 31, 2010 <br />(n) Cost of Revenues <br />Cost of business services revenue primarily includes direct production costs such as labor, patient <br />statement postage and mailings, telecommunications, facility and e- commerce costs. Cost of <br />subscription and other revenue includes labor, hardware, and data center costs. <br />(o) Employee Stock -Based Compensation <br />Compensation expense for all stock -based compensation awards granted is based on the grant date <br />fair value estimated in accordance with the provisions of ASC Topic 718, Stock Compensation (ASC <br />Topic 718). The Company recognizes these compensation costs on a straight -line basis over the <br />requisite service period of the award, which is generally the option vesting term. The Company's <br />options vest over terms of five years. As stock -based compensation expense recognized is based on <br />awards ultimately expected to vest, such expense is generally reduced for estimated forfeitures. ASC <br />Topic 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in <br />subsequent periods if actual forfeitures differ from those estimates. <br />ASC Topic 718 also requires the benefits of income tax deductions in excess of recognized <br />compensation cost to be reported as a cash flow from financing activities, rather than as a cash flow <br />from operating activities. Income tax deductions exceeded recognized compensation costs during the <br />Predecessor period as a result of the acceleration of Predecessor Company stock options in <br />connection with the Merger. No tax benefit was recognized for the Management Incentive Units (MI <br />Units) in the Predecessor period. No such benefits were recognized during the Successor period. <br />The Company estimates the fair value of stock -based compensation awards on the date of grant using <br />the Black - Scholes- Merton (BSM) option pricing model, which was developed for use in estimating <br />the value of traded options that have no vesting restrictions and are freely transferable. The BSM <br />option pricing model considers, among other factors, the expected life of the award and the expected <br />volatility of the Company's stock price. <br />(p) Income Taxes <br />Income taxes are accounted for under the asset and liability method in accordance with ASC <br />Topic 740, Income Taxes (ASC Topic 740). Deferred tax assets and liabilities are recognized for <br />(i) the future tax consequences attributable to differences between the financial statement carrying <br />amounts of existing assets and liabilities and their respective tax bases, and (ii) operating loss and <br />credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates <br />expected to apply to taxable income in the years in which those temporary differences are expected <br />to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is <br />recognized in income in the period that includes the enactment date. <br />We record net deferred tax assets to the extent we believe these assets will more likely than not be <br />realized. In making such determination, we consider all available positive and negative evidence, <br />including future reversals of existing temporary differences, projected future taxable income, tax <br />planning strategies and recent financial operations. It was determined that a valuation allowance was <br />not necessary as of December 31, 2010. <br />13 (Continued) <br />